Glucophage XR is an effective oral medication containing the active ingredient metformin hydrochloride 1000 mg. Metformin belongs to a class of medications known as biguanides, which are a cornerstone of the treatment of type 2 diabetes mellitus.
Glucophage XR features an extended-release (XR) formulation, which allows the medication to be released slowly and steadily into the body over several hours. This feature provides the advantage of taking the medication once daily, improving patient compliance and reducing the likelihood of some of the gastrointestinal side effects associated with immediate-release metformin. Metformin works primarily by reducing glucose production in the liver and increasing peripheral tissue sensitivity to insulin, which helps improve glucose absorption from the blood and thus lower blood sugar levels.
The active ingredient in Glucophage XR
Glucophage XR contains the following active ingredient, which is the basis of its therapeutic effect in managing type 2 diabetes:
Metformin Hydrochloride: 1000 mg in each extended-release tablet. Metformin works on several levels to help control blood sugar. It reduces glucose production in the liver (gluconeogenesis) and improves glucose uptake and utilization by muscles and other tissues. It may also slow glucose absorption from the intestine. Unlike some other diabetes medications, metformin does not directly stimulate insulin secretion, so the risk of low blood sugar (hypoglycemia) is lower when used alone.
Available Strengths
Glucophage XR is typically available in three different strengths of metformin hydrochloride to provide flexible treatment options to suit different patient needs and blood sugar levels:
Metformin Hydrochloride: 500 mg (extended-release): Often used as a starting dose and can be used as a maintenance dose for some patients.
Metformin Hydrochloride: 1000 mg (extended-release): For patients who require a higher dose to achieve optimal blood sugar control.
The appropriate formulation and dose of Glucophage XR are determined individually by a healthcare provider based on a careful assessment of the patient's blood sugar level, response to treatment, kidney function, and any other medical conditions they may have. Treatment is often started at a low dose and gradually increased until the target blood sugar control is achieved.